FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Smith Scott E 		2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1107 GREENLEAF AVE., UNIT 2D 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/10/2010
(Street)

WILMETTE, IL 60091
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.00001 par value                  132550   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options   $7.00                      (1) 5/30/2013   Common Stock, $0.00001 par value   3000     3000   D    
Warrants   $.70                      (1) 12/31/2012   Common Stock, $0.00001 par value   7000     7000   D    
Stock Options   $1.00                      (1) 8/12/2015   Common stock, $0.00001 par value   1000     1000   D    
Stock Options   $0.85                      (1) 3/3/2016   Common stock, $0.00001 par value   20000     20000   D    
Stock Options   $1.25                      (1) 8/11/2016   Common Stock, $0.00001 par value   1000     1000   D    
Stock options   $1.50                      (2) 9/29/2016   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $1.30                    11/12/2009   11/12/2012   Common stock, $0.00001 par value   20000     20000   D    
Warrants   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   10000     10000   D    
Warrants   $1.30                      (1) 7/12/2013   Common stock, $0.00001 par value   32475     32475   D    
Options   $1.72   8/10/2010     A   (3)    14535         (1) 8/10/2017   Common stock $0.00001 par value   14535   $0   (3) 14535   D    

Explanation of Responses:
( 1)  Currently exercisable.
( 2)  Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
( 3)  Annual option award pursuant to the Issuer's compensation policy for Directors upon re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest immediately, and the $1.72 exercise price was set at the average of the close bid and asked prices quoted for the Issuer's common stock on the date of the annual meeting.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Smith Scott E
1107 GREENLEAF AVE.
UNIT 2D
WILMETTE, IL 60091 		X



Signatures
Richard B. Thon by power of attorney 8/11/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.